002817.SHE Anhui Huangshan Capsule Co Ltd
- Market cap
- CNY 1.84B
- P/E
- 29.3x
- P/B
- 1.81x
- ROE
- 6.2%
- Dividend yield
- 1.15%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 002817.SHE undervalued?
Graham number002817.SHE trades 53.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Anhui Huangshan Capsule Co Ltd fundamental analysis
No fundamental analysis for Anhui Huangshan Capsule Co Ltd yet.
Anhui Huangshan Capsule Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Anhui Huangshan Capsule Co Ltd
Anhui Huangshan Capsule Co., Ltd. engages in the research and development, production, and sale of gelatin and enteric-coated gelatin empty capsules in China. The company offers pullulan capsules, entersoluble vacant gelatin capsules, vacant gelatin capsules, vegetable entersoluble capsules, colonsoluble vacant gelatin capsules, hydroxypropyl methyl cellulose hollow capsules, and hydroxypropyl starch hollow capsules. The company was founded in 1989 and is headquartered in Xu…
Full company profileAnhui Huangshan Capsule Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Anhui Huangshan Capsule Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 283M | 286M | 295M | 326M | 319M | 380M | 428M | 463M | 473M | 458M | 380M |
| Gross Profit | 121M | 103M | 98.1M | 118M | 102M | 122M | 117M | 136M | 120M | 127M | 129M |
| Operating Income | 57.7M | 51.8M | 39.4M | 43.1M | 50.9M | 62.0M | 60.9M | 72.0M | 58.9M | 56.8M | 61.5M |
| EBITDA | 79.2M | 78.4M | 65.1M | 71.9M | 79.2M | 95.5M | 106M | 117M | 104M | 105M | 69.2M |
| Net Income | 52.3M | 46.4M | 36.0M | 39.1M | 45.3M | 56.9M | 60.9M | 64.9M | 49.3M | 65.0M | 61.0M |
| EPS | 0.22 | 0.16 | 0.12 | 0.13 | 0.15 | 0.19 | 0.20 | 0.22 | 0.16 | 0.22 | 0.20 |
| Balance Sheet | |||||||||||
| Total Assets | 699M | 739M | 780M | 832M | 916M | 1.05B | 1.04B | 1.10B | 1.09B | 1.11B | 1.13B |
| Total Liabilities | 68.4M | 72.6M | 83.4M | 105M | 151M | 244M | 183M | 202M | 169M | 135M | 144M |
| Shareholders' Equity | 631M | 666M | 693M | 725M | 762M | 810M | 854M | 900M | 916M | 960M | 990M |
| Cash & Short-term Investments | 158M | 248M | 342M | 289M | 342M | 409M | 371M | 244M | 342M | 155M | 158M |
| Total Debt | - | 6.00M | 800K | 22.0M | 15.9M | 75.3M | 274K | 9.91M | 22.1K | 43.3M | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 32.5M | 44.4M | 27.5M | 52.0M | 62.7M | 86.1M | 83.0M | 99.9M | 63.5M | 107M | - |
| Capital Expenditure | 16.4M | 27.5M | 33.2M | 24.7M | 93.8M | 75.8M | 34.1M | 6.58M | 13.6M | 3.87M | 5.23M |
| Free Cash Flow | 16.1M | 17.0M | -5.72M | 27.3M | -31.1M | 10.3M | 48.9M | 93.3M | 49.9M | 104M | 85.6M |
| Ratios | |||||||||||
| ROE | 8.3% | 7.0% | 5.2% | 5.4% | 5.9% | 7.0% | 7.1% | 7.2% | 5.4% | 6.8% | 6.2% |
| ROA | 7.5% | 6.3% | 4.6% | 4.7% | 4.9% | 5.4% | 5.9% | 5.9% | 4.5% | 5.9% | 5.4% |
| Net Profit Margin | 18.4% | 16.2% | 12.2% | 12.0% | 14.2% | 15.0% | 14.2% | 14.0% | 10.4% | 14.2% | 16.1% |
| Debt to Equity | - | 0.01x | 0.00x | 0.03x | 0.02x | 0.09x | 0.00x | 0.01x | 0.00x | 0.05x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Anhui Huangshan Capsule Co Ltd dividends
- Dividend yield
- 1.15%
- Forward dividend
- 0.09 CNY
- Payout ratio
- 32.7%
- Ex-dividend date
- May 26, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 21.2M | 0.07 | 32.7% |
| 2024 | CNY 25.7M | 0.08 | 52.1% |
| 2023 | CNY 18.0M | 0.06 | 27.8% |
| 2022 | CNY 17.1M | 0.06 | 28.1% |
| 2021 | CNY 8.84M | 0.03 | 15.5% |
| 2020 | CNY 8.23M | 0.03 | 18.2% |
| 2019 | CNY 7.37M | 0.03 | 18.8% |
| 2018 | CNY 10.1M | 0.03 | 28.2% |
| 2017 | CNY 11.7M | 0.04 | 25.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.4:1 on Apr 29, 2022.
Who owns Anhui Huangshan Capsule Co Ltd
- Insiders 45.98%
- Institutions 3.89%
- Public & others 50.13%
- Shares outstanding 299M
- Free float 174M
Anhui Huangshan Capsule Co Ltd company profile
- Company name
- Anhui Huangshan Capsule Co Ltd
- Ticker
- 002817.SHE
- ISIN
- CNE100002BV5
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Chemicals
- Employees
- 639
- Fiscal year end
- December
- Address
- No. 7 Huangjia Avenue, Xuancheng, China, 242600
- Phone
- 86 56 3863 0268
- Website
- hsjn.com
About Anhui Huangshan Capsule Co Ltd
Anhui Huangshan Capsule Co., Ltd. engages in the research and development, production, and sale of gelatin and enteric-coated gelatin empty capsules in China. The company offers pullulan capsules, entersoluble vacant gelatin capsules, vacant gelatin capsules, vegetable entersoluble capsules, colonsoluble vacant gelatin capsules, hydroxypropyl methyl cellulose hollow capsules, and hydroxypropyl starch hollow capsules. The company was founded in 1989 and is headquartered in Xuancheng, China.
Anhui Huangshan Capsule Co Ltd management
4- Mr. Song Lin YeGeneral Manager · born 1972
- Mr. Qingke LiuFinancial Director · born 1977
- Mr. Zhenhua ChuDeputy GM & Director · born 1979
- Mr. Wenzheng ZhangVP & Board Secretary · born 1991